As shown in Table 2, double-blind scoring of 87 tissue sections by pathologists confirmed the increased expression of IFITM3 in PCa, and the difference was considered to be statistically significant (P < 0.001). The gene discussed is IFITM3; the disease is posterior cortical atrophy.